IndiaMART (IML) is India's largest online B2B marketplace for business products and services with approximately 60% market share of the online B2B classifieds space in India. IML primarily operates in product and supplier discovery marketplace i.e. www.indiamart.com or IndiaMART. IML earns revenues from the sale of subscription packages, from the sale of request for quote or RFQ credits, advertising from IndiaMART desktop, mobile optimised platforms and revenue from payment facilitation services. As of March 31, 2018, IML had 59.81mn registered buyers, and 4.72mn supplier storefronts in India. These Indian supplier store fronts had listed 50.13mn products, of which 75% of goods comprised products and 25% were...

IPO NOTE

About Q4 results, excluding one-off inventory adjustment in Sun Pharma's domestic business, Q4 results were better than I-direct estimates on all fronts led by robust growth in US and efficient cost control measures. Adjusted revenues of I-direct pharma universe grew 14.9% YoY to | 46359 crore. Overall US pie reported one of the best results in the recent past driven by 1) volume gains, 2) mitigating base business price erosion, 3) new launches and 4) certain one-time sales besides currency tailwinds. Indian formulations also reported decent growth despite soft season in acute...